Ginkgo Bioworks Holdings, Inc. logo

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

Overview | Financials
Company Name Ginkgo Bioworks Holdings, Inc.
Symbol DNA
Currency USD
Price 7.75
Market Cap 430,159,852
Dividend Yield 0%
52-week-range 5.26 - 75.2
Industry Biotechnology
Sector Healthcare
CEO Dr. Jason Kelly
Website https://www.ginkgobioworks.com

An error occurred while fetching data.

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products,

Related Stocks

Teladoc Health, Inc. logo

Teladoc Health, Inc.

TDOC

9.21 USD

Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc.

INSP

190.71 USD

Perrigo Company plc logo

Perrigo Company plc

PRGO

26.09 USD

Penumbra, Inc. logo

Penumbra, Inc.

PEN

233.3 USD

AMN Healthcare Services, Inc. logo

AMN Healthcare Services, Inc.

AMN

36.9 USD

Bausch + Lomb Corporation logo

Bausch + Lomb Corporation

BLCO

20.51 USD

Stevanato Group S.p.A. logo

Stevanato Group S.p.A.

STVN

19.59 USD

Encompass Health Corporation logo

Encompass Health Corporation

EHC

98.91 USD

Financials

Numbers are in millions USD

Numbers are in millions USD